Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Kazuhiro Okafuji"'
Publikováno v:
BMC Anesthesiology, Vol 24, Iss 1, Pp 1-6 (2024)
Abstract Background Left ventricular-arterial coupling is assessed as the ratio of left ventricular end-systolic elastance (Ees) to arterial elastance (Ea). Previous studies have introduced non-invasive estimations of Ees/Ea. It requires only four va
Externí odkaz:
https://doaj.org/article/e88661200e9d4cc39ec4918ec77a7ad5
Autor:
Takahiro Shimizu, Hiroki Shirasaki, Kazuhiro Okafuji, Aiko Sawazaki, Tasuku Iwabuchi, Ryo Matubayashi
Publikováno v:
Respirology Case Reports, Vol 11, Iss 3, Pp n/a-n/a (2023)
Abstract A 54‐year‐old woman presented to our hospital with a fever and cough. The patient had a medical history of follicular lymphoma treated with obinutuzumab. She was infected with an omicron variant of coronavirus disease 2019 and developed
Externí odkaz:
https://doaj.org/article/71c9c4510f08438c9bc414984673fcc1
Autor:
Yukihiro Bando, Hitomi Tohyama, Keiko Aoki, Hideo Kanehara, Azusa Hisada, Kazuhiro Okafuji, Daisyu Toya
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 6, Iss C, Pp 1-7 (2016)
Aims: This preliminary randomized, parallel-group comparative study evaluated the efficacy of ipragliflozin for reduction of small dense low-density lipoprotein cholesterol (sd LDL-C) levels in Japanese patients with type 2 diabetes mellitus (T2DM).
Externí odkaz:
https://doaj.org/article/031132d3b0d742819c1bb8e226f969dc
Autor:
Takahiro Shimizu, Hiroki Shirasaki, Kazuhiro Okafuji, Aiko Sawazaki, Tasuku Iwabuchi, Ryo Matubayashi
Publikováno v:
Respirology Case Reports. 11
Autor:
Go, Aoki, Aiko, Sawazaki, Kazuo, Notsumata, Yasuyuki, Ushiogi, Kazuhiro, Okafuji, Daishu, Toya
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 61(3)
A 78-year-old man was hospitalized because of rapid progression of chronic renal failure and diagnosed with multiple myeloma (MM) IgG-λ type ISS-III R-ISS-II with complex karyotype including t(14;19). Even after receiving bortezomib-based regimens,
Autor:
Daisyu Toya, Hideo Kanehara, Kazuhiro Okafuji, Yukihiro Bando, Azusa Hisada, Keiko Aoki, Hitomi Tohyama
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 6, Iss C, Pp 1-7 (2016)
Journal of Clinical & Translational Endocrinology
Journal of Clinical & Translational Endocrinology
Highlights • Small dense LDL-C (sd LDL-C) convey cardiovascular risk in type 2 diabetes (T2D). • Ipragliflozin reduced sd LDL-C levels in Japanese patients with T2D. • Changes in body weight, TG and LDL-C levels contributed to sd LDL-C reductio
Autor:
Yukihiro Bando, Kazuhiro Okafuji, Daisyu Toya, Keiko Aoki, Nobuyoshi Tanaka, Kousuke Shima, Hideo Kanehara, Azusa Hisada
Publikováno v:
Journal of Diabetes Mellitus. :28-35
Background: Treatment for postprandial glycemia using rapid-acting insulin analogues sometimes resulted in preprandial hypoglycemia or weight gain. Objective: This study evaluated the efficacy and safety of switching bolus insulin from insulin lispro
Autor:
Yukihiro Bando, Kazuhiro Okafuji, Hideo Kanehara, Daisyu Toya, Nobuyoshi Tanaka, Masayuki Yamada, Azusa Hisada, Keiko Aoki
Publikováno v:
Diabetology International. 5:229-233
Aims This study assessed the independent predictors of the hemoglobin A1c (HbA1c)-lowering effect of vildagliptin in Japanese patients with type 2 diabetes.
Autor:
Hideo Kanehara, Kazuo Notumata, Kazuhide Ishikura, Azusa Hisada, Yukihiro Bando, Daisyu Toya, Kazuhiro Okafuji, Ayumi Ogawa
Publikováno v:
Diabetology international. 8(2)
We assessed the effects of a 12-week ipragliflozin treatment on the liver-to-spleen attenuation ratio (L/S ratio) using computed tomography and on alanine transaminase (ALT) levels in Japanese patients with type 2 diabetes mellitus (T2DM). Sixty-two
Autor:
Daisyu Toya, Azusa Hisada, Kazuhiro Okafuji, Yukihiro Bando, Nobuyoshi Tanaka, Hideo Kanehara, Hitomi Toyama
Publikováno v:
Diabetology international. 7(3)
This study investigated the independent predictors of the serum uric acid (sUA)-lowering effect of low-dose febuxostat, a novel xanthine oxidase inhibitor, in Japanese patients with type 2 diabetes mellitus (T2DM). Data of 130 T2DM patients who had b